Patents Examined by D Steadman
  • Patent number: 6664072
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKip3b, antibodies to HsKip3b, methods of screening for HsKip3b modulators using biologically active HsKip3b, and kits for screening for HsKip3b modulators.
    Type: Grant
    Filed: March 4, 2002
    Date of Patent: December 16, 2003
    Assignee: Cytokinetics, Inc.
    Inventors: Christophe Beraud, Richard Freedman
  • Patent number: 6509155
    Abstract: The invention provides mammalian nucleic acid molecules and fragments thereof. It also provides for the use of the mammalian nucleic acid molecules for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with cell signaling, the immune system, and cell proliferation, particularly colon cancer. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid molecules.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: January 21, 2003
    Assignee: Incyte Genomics, Inc.
    Inventors: Tod M. Klinger, Elizabeth A. Stewart, Henry Yue, Mariah R. Baughn
  • Patent number: 6426193
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of HsKif21b, antibodies to HsKif21b, methods of screening for HsKif21b modulators using biologically active HsKif21b, and kits for screening for HsKif21b modulators.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: July 30, 2002
    Assignee: Cytokinetics, Inc.
    Inventors: Christophe Beraud, Richard Freedman